This Latvian Scientist Says His Startup Is Winning The AI Drug Discovery Race
Insilico Medicine, backed by blue-chip investors like Warburg Pincus and Qiming Venture Partners, has 17 preclinical drug candidates so far and earlier this month signed a $500 million licensing deal...